Stay updated on Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial
Sign up to get notified when there's something new on the Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial page.

Latest updates to the Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now states that recruitment has ended, and there are several minor UI edits including new navigation/help items and a wording change for the Intervention/Treatment label, plus an updated revision footer.SummaryDifference0.4%

- Check19 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5, indicating a new build of the page was deployed. This reflects a metadata-level update rather than substantive content changes.SummaryDifference0.0%

- Check41 days agoChange DetectedThe page revision label was updated from v3.5.3 to v3.5.4, indicating a new release of the study page. This change does not alter the trial data, eligibility criteria, or other substantive content.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page’s display version/revision indicator was updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check69 days agoChange DetectedRevision tag updated from v3.5.0 to v3.5.2 on the page.SummaryDifference0.0%

- Check98 days agoChange DetectedA new frontend revision v3.5.0 is implemented, replacing the previous revision v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial page.